2009

• de Zwaan, S., Iland, H., Damian, D. (2009), Treatment of refractory pyoderma gangrenosum with intravenous immunoglobulin. The Australasian Journal of Dermatology. 50(1), 56-59. [Abstract]

2007

• Catalano, A., Dawson, M., Somana, K., Opat, S., Schwarer, A., Campbell, L., Iland, H. (2007), The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemia. Blood. 110(12), 4073-6. [Abstract]
• Sanders, J., Crawford, B., Gibson, J., Joy Ho, P., Iland, H., Joshua, D. (2007), Is there a case for the early use of bisphosphonates in smouldering myeloma and MGUS? (Bisphosphonates in SMM & MGUS). International journal of laboratory hematology. , 395-397. [Abstract]
• Young, G., Iland, H. (2007), Clinical perspectives in lymphoma. Internal medicine journal. 37(7), 478-484. [Abstract]
• Losco, P., Brown, R., Iland, H., Uhr, E., Lee, L., Joshua, D. (2007), An evaluation of the technical performance and clinical applications of the Beckman Coulter Access® Erythropoietin immunoassay. Australian Journal of Medical Science. 28(4), 139-144.

2006

• Ling, S., Joshua, D., Gibson, J., Young, G., Iland, H., Watson, G., Ho, P. (2006), Transformation and progression of Waldenström's macroglobulinemia following cladribine therapy in two cases: natural evolution or iatrogenic causation?. American journal of hematology. 81(2), 110-4. [Abstract]